furosemid bbp 10 mg/ml
bb pharma a.s., Česká republika - furosemid - 50 - diuretica
multivitamín forte želé
crysvita
kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - lieky na liečbu chorôb kostí - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.
veyx-pharma gmbh, 34639 schwarzenborn, spolková republika nemecko.
veyx-pharma gmbh, söhreweg 6, d-34639 schwarzenborn, nemecko
neurotop 200 mg
g.l. pharma gmbh, rakúsko - karbamazepín - 21 - antiepileptica, anticonvulsiva
calcivet es sol.
multivitamin injekčný roztok
norbrook laboratories ltd., Írsko - inj.
biochem zusatzstoffe handels- und produktionsgesellschaft mbh,